142 related articles for article (PubMed ID: 2784735)
1. Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells.
Uchiyama T; Kamagata Y; Yan XJ; Kawachi A; Fujikawa H; Igarashi H; Okubo M
Clin Exp Immunol; 1989 Feb; 75(2):239-44. PubMed ID: 2784735
[TBL] [Abstract][Full Text] [Related]
2. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.
Micusan VV; Mercier G; Bhatti AR; Reiser RF; Bergdoll MS; Oth D
Immunology; 1986 Jun; 58(2):203-8. PubMed ID: 3486824
[TBL] [Abstract][Full Text] [Related]
3. Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.
Uchiyama T; Kamagata Y; Yan XJ; Kohno M; Yoshioka M; Fujikawa H; Igarashi H; Okubo M; Awano F; Saito-Taki T
Clin Exp Immunol; 1987 Jun; 68(3):638-47. PubMed ID: 3498581
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
5. Acute systemic immune activation following vaginal exposure to staphylococcal enterotoxin B--implications for menstrual shock.
Rajagopalan G; Smart MK; Murali N; Patel R; David CS
J Reprod Immunol; 2007 Feb; 73(1):51-9. PubMed ID: 17070600
[TBL] [Abstract][Full Text] [Related]
6. Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock.
Ferry T; Thomas D; Perpoint T; Lina G; Monneret G; Mohammedi I; Chidiac C; Peyramond D; Vandenesch F; Etienne J
Clin Microbiol Infect; 2008 Jun; 14(6):546-54. PubMed ID: 18373692
[TBL] [Abstract][Full Text] [Related]
7. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
Miethke T; Wahl C; Heeg K; Wagner H
J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
[TBL] [Abstract][Full Text] [Related]
9. Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells.
Chatila T; Wood N; Parsonnet J; Geha RS
J Immunol; 1988 Feb; 140(4):1250-5. PubMed ID: 2830336
[TBL] [Abstract][Full Text] [Related]
10. Induction of murine hemopoietic growth factors by toxic shock syndrome toxin-1.
Galelli A; Anderson S; Charlot B; Alouf JE
J Immunol; 1989 Apr; 142(8):2855-63. PubMed ID: 2784816
[TBL] [Abstract][Full Text] [Related]
11. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
De Boer ML; Kum WW; Pang LT; Chow AW
Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
Kum WW; Chow AW
J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
[TBL] [Abstract][Full Text] [Related]
13. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
Arad G; Levy R; Hillman D; Kaempfer R
Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
[TBL] [Abstract][Full Text] [Related]
14. Secretion of IL-6, IL-8 and G-CSF by human endothelial cells in vitro in response to Staphylococcus aureus and staphylococcal exotoxins.
Söderquist B; Källman J; Holmberg H; Vikerfors T; Kihlström E
APMIS; 1998 Dec; 106(12):1157-64. PubMed ID: 10052724
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype.
Mollick JA; Chintagumpala M; Cook RG; Rich RR
J Immunol; 1991 Jan; 146(2):463-8. PubMed ID: 1987273
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of toxic shock syndrome by two different systems; clinical criteria and monitoring of TSST-1-reactive T cells.
Matsuda Y; Kato H; Ono E; Kikuchi K; Muraoka M; Takagi K; Imanishi K; Itoh S; Itoh T; Ogawa T; Nitta K; Inokuchi S; Hibi T; Ohta H; Uchiyama T
Microbiol Immunol; 2008 Nov; 52(11):513-21. PubMed ID: 19090830
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
De Boer ML; Kum WW; Chow AW
Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
[TBL] [Abstract][Full Text] [Related]
18. Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome.
Dinges MM; Gregerson DS; Tripp TJ; McCormick JK; Schlievert PM
J Infect Dis; 2003 Oct; 188(8):1142-5. PubMed ID: 14551884
[TBL] [Abstract][Full Text] [Related]
19. Study of the biological activities of toxic shock syndrome toxin-1. I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin.
Uchiyama T; Kamagata Y; Wakai M; Yoshioka M; Fujikawa H; Igarashi H
Microbiol Immunol; 1986; 30(5):469-83. PubMed ID: 3489157
[TBL] [Abstract][Full Text] [Related]
20. A severe case of neonatal toxic shock syndrome-like exanthematous disease with superantigen-induced high T cell response.
Miki M; Uchiyama T; Kato H; Nishida H; Takahashi N
Pediatr Infect Dis J; 2006 Oct; 25(10):950-2. PubMed ID: 17006297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
